Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivery Optimization for Antiretrovial Therapy (The DO ART Study): A Prospective, Interventional, Randomized Study of Community-based ART Initiation, Delivery, and Monitoring in South Africa and Uganda

NCT02929992 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02929992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02929992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivery Optimization for Antiretrovial Therapy (The DO ART Study): A Prospective, Interventional, Randomized Study of Community-based ART Initiation, Delivery, and Monitoring in South Africa and Uganda
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
January 21, 2020
Enrollment
1,539 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

art, hiv